Evidence map›Paper›PMID 29992433›Full record

ArticleJournal of neuro-oncology2018

Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.

Christian F Freyschlag, Sandro M Krieg, Johannes Kerschbaumer, Daniel Pinggera, Marie-Therese Forster, Dominik Cordier, Marco Rossi, Gabriele Miceli, Alexandre Roux, Andrés Reyes and 25 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Prognostic Factors of Low-Grade Gliomas in Adults.Current oncology (Toronto, Ont.) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Ivosidenib in Isocitrate Dehydrogenase 1Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 12 countries.

Christian F FreyschlagDepartment of Neurosurgery, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. christian.freyschlag@i-med.ac.at.
Sandro M KriegDepartment of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Johannes KerschbaumerDepartment of Neurosurgery, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Daniel PinggeraDepartment of Neurosurgery, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Marie-Therese ForsterDepartment of Neurosurgery, Goethe University Hospital, Frankfurt am Main, Germany.
Dominik CordierDepartment of Neurosurgery, Universitätsspital Basel, Basel, Switzerland.
Marco RossiNeurosurgical Oncology Unit, Humanitas Research Hospital, IRCCS, Milan, Italy.
Gabriele MiceliCenter for Mind/Brain Sciences, University of Trento, Rovereto, Italy.
Alexandre RouxDepartment of Neurosurgery, Sainte-Anne Hospital, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
Andrés ReyesEuropean Master's in Clinical Linguistics (EMCL), University of Groningen, Groningen, The Netherlands.
Silvio SarubboDivision of Neurosurgery, Structural and Functional Connectivity Lab Project, "S. Chiara" Hospital, APSS, Trento, Italy.
Anja SmitsDepartment of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Joanna SierpowskaCognition and Brain Plasticity Unit, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Barcelona, Spain.
Pierre A RobeDepartment of Neurology and Neurosurgery, Rudolf Magnus Brain Institute, University Medical Center of Utrecht, Utrecht, The Netherlands.
Geert-Jan RuttenDepartment of Neurosurgery, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands.
Thomas SantariusDepartment of Neurosurgery, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Tomasz MatysDepartment of Radiology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Marc ZanelloDepartment of Neurosurgery, Sainte-Anne Hospital, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
Fabien AlmairacNeurosurgery Department, Hôpital Pasteur 2, University Hospital of Nice, Nice, France.
Lydiane MondotRadiology Department, Hôpital Pasteur 2, University Hospital of Nice, Nice, France.
Asgeir S JakolaDepartment of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Maria ZetterlingDepartment of Neurosurgery, Institution of Neuroscience, Uppsala University Hospital, Uppsala, Sweden.
Adrià RofesGlobal Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Gord von CampeDepartment of Neurosurgery, Medical University Graz, Graz, Austria.
Remy GuillevinDACTIM, UMR CNRS 7348, Université de Poitiers et CHU de Poitiers, Poitiers, France.
Daniele BagattoNeuroradiology Department, University Hospital Santa Maria della Misericordia, Udine, Italy.
Vincent LubranoDepartment of Neurosurgery, CHU Toulouse, Toulouse, France.
Marion RappDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
John GooddenDepartment of Neurosurgery, The General Infirmary at Leeds, Leeds, West Yorkshire, UK.
Philip C De Witt HamerVU University Medical Center, Amsterdam, The Netherlands.
Johan PalludDepartment of Neurosurgery, Sainte-Anne Hospital, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
Lorenzo BelloNeurosurgical Oncology Unit, Humanitas Research Hospital, IRCCS, Milan, Italy.
Claudius ThoméDepartment of Neurosurgery, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Hugues DuffauDepartment of Neurosurgery, Hôpital Gui de Chauliac, Montpellier Medical University Center, Montpellier, France.
Emmanuel MandonnetDepartment of Neurosurgery, Lariboisière Hospital, APHP, Paris, France.
Universität Innsbruck · ATDélégation Paris 5 · FRHôpital Pasteur · FRIRCCS Humanitas Research Hospital · ITAddenbrooke's Hospital · GBAmsterdam UMC Location Vrije Universiteit Amsterdam · NLAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Toulouse · FRCentre National de la Recherche Scientifique · FRElisabeth-TweeSteden Ziekenhuis · NLHeinrich Heine University Düsseldorf · DEInstitut d'Investigació Biomédica de Bellvitge · ESInstitute for Neurosciences of Montpellier · FRKlinikum rechts der Isar · DELeeds General Infirmary · GBMedical University of Graz · ATOspedale Santa Chiara · ITOspedale Santa Maria della Misericordia di Udine · ITSahlgrenska University Hospital · SESorbonne Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveImaging studies in diffuse low-grade gliomas (DLGG) vary across centers. In order to establish a minimal core of imaging necessary for further investigations and clinical trials in the field of DLGG, we aimed to establish the status quo within specialized European centers.

methodsAn online survey composed of 46 items was sent out to members of the European Low-Grade Glioma Network, the European Association of Neurosurgical Societies, the German Society of Neurosurgery and the Austrian Society of Neurosurgery.

resultsA total of 128 fully completed surveys were received and analyzed. Most centers (n = 96, 75%) were academic and half of the centers (n = 64, 50%) adhered to a dedicated treatment program for DLGG. There were national differences regarding the sequences enclosed in MRI imaging and use of PET, however most included T1 (without and with contrast, 100%), T2 (100%) and TIRM or FLAIR (20, 98%). DWI is performed by 80% of centers and 61% of centers regularly performed PWI.

conclusionA minimal core of imaging composed of T1 (w/wo contrast), T2, TIRM/FLAIR, PWI and DWI could be identified. All morphologic images should be obtained in a slice thickness of ≤ 3 mm. No common standard could be obtained regarding advanced MRI protocols and PET. IMPORTANCE OF THE STUDY: We believe that our study makes a significant contribution to the literature because we were able to determine similarities in numerous aspects of LGG imaging. Using the proposed "minimal core of imaging" in clinical routine will facilitate future cooperative studies.

Indexed as

SpecializationBrain NeoplasmsEuropeGliomaHumansMagnetic Resonance ImagingNeoplasm GradingNeurosurgical ProceduresPractice Guidelines as TopicPractice Patterns, Physicians'Surveys and QuestionnairesImaging in LGGLow-grade gliomaMinimal core of imagingResponse criteria

Identifiers

PMID29992433
PMCPMC6132968
OpenAlexW2878167975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.